Hee Rim Nam
Sungkyunkwan University · 医学
研究室紹介
Professor Hee Rim Nam's research lab specializes in radiation oncology, with a primary focus on optimizing treatment strategies for patients with gastrointestinal, head and neck, and nasopharyngeal cancers. The lab investigates prognostic factors such as tumor volume reduction rate (TVRR) and pathological response after chemoradiotherapy to guide adaptive and personalized radiation therapy. Key research directions include improving the precision and efficacy of intensity-modulated and volumetric-modulated arc therapy (IMRT/VMAT), evaluating the role of palliative radiotherapy in metastatic disease, and exploring dosimetric advantages of multileaf collimator design in treatment delivery. The lab emphasizes evidence-based, patient-centered approaches to enhance long-term outcomes and quality of life.
Research Overview
Research Output Trend
Figures are computed from collected data and may differ slightly.
Selected Papers
15LARC patients achieving ypT0N0 after preoperative CRT had favorable long-term outcomes, whereas positive ypN status had a poor prognosis even after total regression of primary tumor.
BACKGROUND: To evaluate the palliative role of radiotherapy (RT) and define the effectiveness of chemotherapy combined with palliative RT (CCRT) in patients with a symptomatic pelvic mass of metastatic colorectal cancer. METHODS: From August 1995 to December 2007, 80 patients with a symptomatic pelvic mass of metastatic colorectal cancer were treated with palliative RT at Samsung Medical Center. Initial presenting symptoms were pain (68 cases), bleeding (18 cases), and obstruction (nine cases).
TVRR proved to be a significant prognostic factor in NPC patients treated with definitive RT, and could be used as a potential indicator for early therapeutic modification during the RT course.
BACKGROUND: The purpose of this study was to evaluate the prognostic significance of the tumor volume reduction rate (TVRR) measured during adaptive definitive radiation therapy (RT) in patients with oropharyngeal cancer. METHODS: We reviewed the RT records of 59 patients with oropharyngeal cancer who were treated with definitive RT with or without concurrent chemotherapy between January 2006 and October 2010. Adaptive replanning was performed in all patients during RT. The pre-RT and mid-RT gro
PURPOSE: The authors evaluated the effects of multileaf collimator (MLC) leaf width (2.5 vs. 5 mm) on dosimetric parameters and delivery efficiencies of intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) for head and neck (H&N) cancers. METHODS: The authors employed two types of mock phantoms: large-sized head and neck (LH&N) and small-sized C-shape (C-shape) phantoms. Step-and-shoot IMRT (S&S_IMRT) and VMAT treatment plans were designed with 2.5- and 5.0-mm
The clinical outcomes by the current SNI policy were feasible and comparable to those following classic elective nodal irradiation policy.
SBRT for spinal metastases from HCC is well tolerated and effective at providing pain relief and radiologic response. Because compression fractures develop at a high rate following SBRT for spinal metastases from primary HCC, careful follow up of the patient is required.